These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 22426576

  • 1. Electroretinographic (ERG) responses in pediatric patients using vigabatrin.
    Moskowitz A, Hansen RM, Eklund SE, Fulton AB.
    Doc Ophthalmol; 2012 Jun; 124(3):197-209. PubMed ID: 22426576
    [Abstract] [Full Text] [Related]

  • 2. Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort.
    Dragas R, Westall C, Wright T.
    Doc Ophthalmol; 2014 Oct; 129(2):97-104. PubMed ID: 25008578
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss.
    Harding GF, Wild JM, Robertson KA, Rietbrock S, Martinez C.
    Neurology; 2000 Aug 08; 55(3):347-52. PubMed ID: 10932265
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy.
    Kjellström U, Lövestam-Adrian M, Andréasson S, Ponjavic V.
    Doc Ophthalmol; 2008 Sep 08; 117(2):93-101. PubMed ID: 18188629
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Binasal visual field defects are not specific to vigabatrin.
    Gonzalez P, Sills GJ, Parks S, Kelly K, Stephen LJ, Keating D, Dutton GN, Brodie MJ.
    Epilepsy Behav; 2009 Nov 08; 16(3):521-6. PubMed ID: 19815465
    [Abstract] [Full Text] [Related]

  • 12. Retinal function abnormalities in patients treated with vigabatrin.
    Banin E, Shalev RS, Obolensky A, Neis R, Chowers I, Gross-Tsur V.
    Arch Ophthalmol; 2003 Jun 08; 121(6):811-6. PubMed ID: 12796251
    [Abstract] [Full Text] [Related]

  • 13. Examining visual field defects in the paediatric population exposed to vigabatrin.
    Spencer EL, Harding GF.
    Doc Ophthalmol; 2003 Nov 08; 107(3):281-7. PubMed ID: 14711160
    [Abstract] [Full Text] [Related]

  • 14. Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.
    Westall CA, Wright T, Cortese F, Kumarappah A, Snead OC, Buncic JR.
    Neurology; 2014 Dec 09; 83(24):2262-8. PubMed ID: 25381295
    [Abstract] [Full Text] [Related]

  • 15. Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children.
    Harding GF, Spencer EL, Wild JM, Conway M, Bohn RL.
    Neurology; 2002 Apr 23; 58(8):1261-5. PubMed ID: 11971096
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Photoreceptor and postreceptor responses in congenital stationary night blindness.
    Raghuram A, Hansen RM, Moskowitz A, Fulton AB.
    Invest Ophthalmol Vis Sci; 2013 Jul 10; 54(7):4648-58. PubMed ID: 23761088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.